sábado, 19 de enero de 2013

Roundtable Review 2012: Year In Review

December 31, 2012

The year 2012 has witnessed seminal advances in the field of science, such as definitive proof of the existence of the Higgs boson, the Curiosity rover landing on Mars and developments in genomics, cancer and stem cell research. Roundtable Review featured articles covering such major breakthroughs in science and biotechnology, in addition to articles on science basics, policy, event coverage, and interviews that were well received by our readers. We present Roundtable Review 2012: Year In Review, a list of our ten most popular and prominent articles from 2012.

February 13, 2012
This article discusses the essential role biotech plays in bringing science ‘from bench to bedside’ and the sea of failures that necessitate a closer look into the sustainability of ‘biotech’.

March 28, 2012
This article describes how pharmaceutical companies are changing their approach by collaborating with academia for basic research.

July 19, 2012
This article discusses the battle between Samsung and Apple on intellectual property and patent infringements.

August 19, 2012
This in-depth article covers the basics, recent advancements, ethics, and translational significance of next generation sequencing.

November 2, 2012
This article talks about patents and the UK Patents Act.

November 4, 2012
This article describes experiences of a consultant working with ORS, a unique Oxbridge Biotech Roundtableplatform for consultancy on science and entrepreneurship.

Nov 10, 2012
Jack Florio of Tech Coast Angels discusses the current biotech climate in San Diego.

Nov 21, 2012
This is an article that reviews and discusses a study on creating embryos in which defective mitochondrial DNA was replaced by healthy donor mitochondrial DNA.

December 3, 2012
This article is an overview of the ENCODE project (the Encyclopedia of DNA Elements) considered to be one of the biggest breakthroughs in the field of genomics.

December 26, 2012
Professor Bayley discusses education and straddling the line between academia and business.

2013 comes with a lot of promise for the field of science and for us at OBR with plans for various activities, workshops and increasing opportunities for consultancy. We look forward to continue presenting prominent articles in science on Roundtable Review in the coming year and hope that 2013 brings major advances along with higher funding for science and increased productive collaborations between academia, biotech and pharmaceutical industries. We wish everyone a Happy 2013!

No hay comentarios:

Publicar un comentario